Dahili, Fe B.
HRN: 29-02-62 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
CO-AMOXICLAV 625MG (TAB)
05/20/2026
05/27/2026
PO
625MG
BID
LACERATED WOUND HEAD AND EAR
Checking Initial Appropriateness